Dynamic Medical Technologies (ROCO:4138) Research & Development: NT$0 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4138 Dynamic Medical Technologies Inc ROCO:4138
78 GF Score
Price NT$50.90
GF Value NT$74.17
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Dynamic Medical Technologies Research & Development?

Dynamic Medical Technologies ROCO:4138 +0.39% 78 Research & Development is NT$0 Mil as of Dec. 2025. GuruFocus rates ROCO:4138 with a GF Score™ of 78/100 and a GF Value™ of NT$74.17 (Significantly Undervalued). The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Dynamic Medical Technologies's Research & Development for the three months ended in Dec. 2025 was NT$0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was NT$0 Mil.

Dynamic Medical Technologies  (ROCO:4138) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Dynamic Medical Technologies Research & Development Related Terms

Dynamic Medical Technologies Research & Development Historical Data

* Premium members only.

The historical data trend for Dynamic Medical Technologies's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dynamic Medical Technologies Research & Development Chart

Dynamic Medical Technologies Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Dynamic Medical Technologies Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ROCO:4138
78GF Score
Dynamic Medical Technologies Inc ROCO:4138
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dynamic Medical Technologies Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of NT$0 Mil mean?
Dynamic Medical Technologies (ROCO:4138) has a Research & Development of NT$0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Dynamic Medical Technologies and its competitors.
Is Dynamic Medical Technologies' Research & Development too high?
Dynamic Medical Technologies' current Research & Development is NT$0 Mil. Overall, Dynamic Medical Technologies has a GF Score™ of 78/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dynamic Medical Technologies' Research & Development compare to ABT and SYK?
Dynamic Medical Technologies' Research & Development of NT$0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Dynamic Medical Technologies and its competitors. Dynamic Medical Technologies's current Research & Development is NT$0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dynamic Medical Technologies stock overvalued right now?
Based on GuruFocus' analysis, Dynamic Medical Technologies (ROCO:4138) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$74.17, compared to a current price of NT$50.90 — trading 31.4% below its estimated fair value. The current Research & Development is NT$0 Mil. Dynamic Medical Technologies' overall GF Score™ is 78/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Dynamic Medical Technologies (ROCO:4138), the current Research & Development is NT$0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dynamic Medical Technologies (ROCO:4138) Overvalued in 2026?

Based on GuruFocus' analysis, Dynamic Medical Technologies stock appears to be undervalued. The current stock price of NT$50.90 is trading 31.4% below its estimated GF Value™ of NT$74.17. GuruFocus considers Dynamic Medical Technologies to be Significantly Undervalued.

Key valuation signals for ROCO:4138:

  • Research & Development: NT$0 Mil
  • GF Value™: NT$74.17 vs. price of NT$50.90 (31.4% below fair value)
  • GF Score™: 78/100 with 4 warning signs

No single metric tells the full story. See the ROCO:4138 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Dynamic Medical Technologies Business Description

Address No. 880, Zhongzheng Road, 14th Floor, Zhonghe District, New Taipei City, TWN, 23586
Dynamic Medical Technologies Inc is engaged in the sales, maintenance, and integrated marketing of aesthetic lasers and light-based equipment. The company's product line includes aesthetic medical devices, body contouring devices, dermal fillers, and cosmeceuticals. The reportable segments after the adjustment are the Medical equipment trading segment and the Beauty channel segment. The Medical equipment trading segment includes selling, leasing, and repairing medical aesthetic equipment and selling the medical aesthetic consumables and cosmetic products. The Beauty channel segment generates revenues from the sale of lifestyle beauty products and treatments at physical store, as well as the sale of medical aesthetic products.
78GF Score

Get the complete analysis for ROCO:4138

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$50.90
Price
NT$74.17
GF Value